Back
Cartesian Therapeutics Stock Price Chart
Sponsored
RNAC
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
RNAC
Cartesian Therapeutics
Last Price:
16.93
Seasonality Move:
13.13%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
Cartesian Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.66 | Sell |
20-day SMA: | 19.51 | Sell |
50-day SMA: | 19.31 | Sell |
200-day SMA: | 20 | Sell |
8-day EMA: | 17.92 | Sell |
20-day EMA: | 18.95 | Sell |
50-day EMA: | 19.03 | Sell |
200-day EMA: | 21.01 | Sell |
Cartesian Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.75 | Sell |
Relative Strength Index (14 RSI): | 39.42 | Sell |
Chaikin Money Flow: | -99129 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.09 - 22.05) | Sell |
Bollinger Bands (100): | (14.31 - 20.45) | Sell |
Cartesian Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 16.94 while RNAC 8-day simple moving average is 17.66, which is a Sell signal.
- The stock price of RNAC is 16.94 while Cartesian Therapeutics 20-day SMA is 19.51, which makes it a Sell.
- Cartesian Therapeutics 50-day simple moving average is 19.31 while RNAC share price is 16.94, making it a Sell technically.
- RNAC stock price is 16.94 and Cartesian Therapeutics 200-day simple moving average is 20.00, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
26
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a Sell
The current Cartesian Therapeutics [RNAC] share price is $16.94. The Score for RNAC is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
430.53M
Price in USD:
16.94
Share Volume:
114.38K
Cartesian Therapeutics 52-Week Range
52-Week High:
42.60
52-Week Low:
11.67
Sell
26
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?
The Cartesian Therapeutics stock price is 16.94 USD today. -
Will RNAC stock go up or go down?
Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cartesian Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
- Cartesian Therapeutics share price is 16.94 while RNAC 8-day exponential moving average is 17.92, which is a Sell signal.
- The stock price of RNAC is 16.94 while Cartesian Therapeutics 20-day EMA is 18.95, which makes it a Sell.
- Cartesian Therapeutics 50-day exponential moving average is 19.03 while RNAC share price is 16.94, making it a Sell technically.
- RNAC stock price is 16.94 and Cartesian Therapeutics 200-day simple moving average is 21.01, creating a Sell signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
- RNAC Moving Average Covergence Divergence (MACD) indicator is -0.75, suggesting Cartesian Therapeutics is a Sell
- Cartesian Therapeutics Relative Strength Index (RSI) is 39.42, which suggest Cartesian Therapeutics is oversold
- The Bollinger Bands (25) for Cartesian Therapeutics is (18.09 - 22.05), which suggest Cartesian Therapeutics is a Sell
- The Bollinger Bands (100) for Cartesian Therapeutics is (14.31 - 20.45), which suggest Cartesian Therapeutics is a Sell
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.